Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
about
Has the DOTS strategy improved case finding or treatment success? An empirical assessmentTuberculosis in Kazakhstan: analysis of risk determinants in national surveillance dataImpact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysisGatifloxacin and ethionamide as the foundation for therapy of tuberculosisFew amino acid positions in rpoB are associated with most of the rifampin resistance in Mycobacterium tuberculosisFeasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the PhilippinesIs HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic reviewEffect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysisSterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosisHigh-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosisNitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosisInositol monophosphate phosphatase genes of Mycobacterium tuberculosisAnti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national surveyGenoType MTBDRplus Assay for Rapid Detection of Multidrug Resistance in Mycobacterium tuberculosis: A Meta-AnalysisAn ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid compositionAdaptation of a web-based, open source electronic medical record system platform to support a large study of tuberculosis epidemiologyUse of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis.Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis.A non-sense mutation in the putative anti-mutator gene ada/alkA of Mycobacterium tuberculosis and M. bovis isolates suggests convergent evolution.M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.Characterization of Mycobacterium tuberculosis Central Asian Strain 1 using mycobacterial interspersed repetitive unit genotyping.Treatment of isoniazid-resistant pulmonary tuberculosis.Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysisA synthetic mammalian gene circuit reveals antituberculosis compounds.Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study.Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis.Epidemiology and treatment of multidrug resistant tuberculosisMolecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphismGenetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in TaiwanIdentification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.Susceptibility Pattern and Epidemiology of Mycobacterium tuberculosis in United Emirati HospitalNanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy.Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, UgandaGenomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosisrpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.Spoligotyping of Mycobacterium tuberculosis isolates from multiple-drug-resistant tuberculosis patients from Bombay, India.Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.
P2860
Q21144342-36A87690-5018-4B30-9162-B891D05BD8D1Q21261815-D3AADD1D-2298-4566-B89E-5C95448C5E23Q24554274-EFFFE712-E18E-4209-8FE9-565D32981F8EQ24680317-784C4831-4C27-4710-ABBE-C943A18F0DDFQ24804809-00C2FA52-4136-46BE-89EF-5CDD1592E5CCQ28469046-5CBA7C0C-EA74-4322-AFF7-0228159B5566Q28475509-A6E04C8A-7788-4777-BD89-F6897B9D3FF8Q28476120-70DE67F5-63F1-49B6-B8C2-5ED2D9B4B6F7Q28477317-02124589-96F7-4A75-96FC-C68F18F514FCQ28481039-4332567A-C220-4ECA-9643-02DC29BEFD4BQ28483646-0A653FFA-DDB1-4659-A310-B7DD2394290EQ28487227-A6141E3C-29EA-4DAA-B599-7B46499C3DC0Q28535035-73DBDF15-9DD9-4403-8E81-78317A714E41Q28550477-6D31999C-8D01-4379-8954-1F3015705AD4Q28659734-0DED11E8-3499-49DD-8E20-2E7C2BE8A6DCQ28710179-7C78B21F-477E-406C-AA3D-AD33468B2A58Q31089497-B2688C4F-57B8-4D9B-9F85-D351001DEC8FQ31119394-914724C4-3D49-4DC9-BBCB-4F78D5409FF1Q33244525-44332189-6B6F-4F28-98DE-7F1774A397E4Q33284831-5C8CA86A-44A5-4652-A0C2-302E320BCE4DQ33286329-112FDEDB-7C1E-418A-9632-D7BFBA7A1B56Q33293632-28DC9922-1C12-4A30-8A1E-8397177CB663Q33315736-A3960973-971D-480F-A749-E8B01015E951Q33340828-B8881FD8-FEEE-4E69-B548-21023B8E70F5Q33351251-0C579F74-B96D-4EE0-99E8-C1E0B611E842Q33389187-123E68CC-DE8F-4D00-B25F-738943FBAEDBQ33534907-FF638A19-B050-44A8-B191-D35E12AB34D7Q33654669-AF753D61-FC66-48F2-967C-13CEA2F2DAA1Q33710690-D5BD8A12-DAF7-44D4-8684-9647C480F242Q33722028-DA4681EA-A9ED-4A8A-B460-EFC747CD96AFQ33753105-2C187E9A-A3E3-465C-BACB-E0F2D8F9F48EQ33826352-E0129019-2A89-481D-97B2-D81DE4E0382CQ33829247-F90BDC69-65A9-4B69-BF5E-8DFF87DC7F67Q33854476-31FBB6D5-EB2B-41BC-8D44-25ACC3B3B361Q33904830-57284761-0DF9-4C0F-92DC-64712AF6DC5DQ33935481-C126991A-FE15-4EE3-AD7E-7D2DCD98F062Q33951187-95A5B168-A967-415D-B0DE-AC9E37EF4D9BQ33952004-5813D780-5EE6-4D88-9C41-D9A5BF415BBCQ33963107-029DD09B-59AA-4BED-BD4E-035CDB5A3C0AQ34030008-B60D83A7-08AE-483E-B16A-3987EB33DD8B
P2860
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Global trends in resistance to ...... Drug Resistance Surveillance.
@en
Global trends in resistance to ...... Drug Resistance Surveillance.
@nl
type
label
Global trends in resistance to ...... Drug Resistance Surveillance.
@en
Global trends in resistance to ...... Drug Resistance Surveillance.
@nl
prefLabel
Global trends in resistance to ...... Drug Resistance Surveillance.
@en
Global trends in resistance to ...... Drug Resistance Surveillance.
@nl
P2093
P1476
Global trends in resistance to ...... Drug Resistance Surveillance.
@en
P2093
Boulahbal F
Espinal MA
Raviglione MC
P304
P356
10.1056/NEJM200104263441706
P407
P577
2001-04-01T00:00:00Z